Votoplam
- Generic Name
- Votoplam
An Extension Study to Evaluate the Long-Term Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- PTC Therapeutics
- Target Recruit Count
- 250
- Registration Number
- NCT06254482
- Locations
- 🇦🇹
Medical University Innsbruck, Innsbruck, Austria
🇦🇺Westmead Hospital, Westmead, Australia
🇨🇦The Ottawa Hospital, Parkinson's and Movement Disorders Clinic, Ottawa, Canada
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
- First Posted Date
- 2022-05-03
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- PTC Therapeutics
- Target Recruit Count
- 252
- Registration Number
- NCT05358717
- Locations
- 🇩🇪
Charite University Medicine Berlin, Berlin, Germany
🇺🇸University of California, San Diego, La Jolla, California, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath